Clinical Trial Update: COvid-19 and Vitamin D Supplementation: a Multicenter Randomized Controlled Trial of High Dose Versus Standard Dose Vitamin D3 in High-risk COVID-19 Patients (CoVitTrial) [Phase 3]

View source ↗

Summary

Phase 3 randomized trial comparing high-dose versus standard-dose Vitamin D3 in high-risk COVID-19 patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronavirus

Drugs mentioned

• Vitamin D3 (Cholecalciferol)

Snippet

Sponsor: University Hospital, Angers | Conditions: Coronavirus | Phase 3 | Status: COMPLETED